Christopher B. Doering

2.6k total citations
107 papers, 2.0k citations indexed

About

Christopher B. Doering is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Christopher B. Doering has authored 107 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 46 papers in Molecular Biology and 44 papers in Oncology. Recurrent topics in Christopher B. Doering's work include Hemophilia Treatment and Research (43 papers), CAR-T cell therapy research (41 papers) and Virus-based gene therapy research (39 papers). Christopher B. Doering is often cited by papers focused on Hemophilia Treatment and Research (43 papers), CAR-T cell therapy research (41 papers) and Virus-based gene therapy research (39 papers). Christopher B. Doering collaborates with scholars based in United States, Germany and India. Christopher B. Doering's co-authors include H. Trent Spencer, Pete Lollar, Ernest T. Parker, Bagirath Gangadharan, Harrison C. Brown, John F. Healey, Gabriela Denning, Rachel T. Barrow, Dean J. Danner and Robert Moot and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Christopher B. Doering

104 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher B. Doering United States 26 887 832 781 780 286 107 2.0k
Karen Clise-Dwyer United States 23 248 0.3× 795 1.0× 781 1.0× 329 0.4× 1.1k 3.7× 54 2.2k
P. Joy Ho Australia 25 1.3k 1.5× 937 1.1× 891 1.1× 138 0.2× 786 2.7× 113 2.2k
Joachim Schwäble Germany 22 1.1k 1.2× 1.2k 1.5× 487 0.6× 343 0.4× 259 0.9× 33 2.1k
John Marken United States 9 587 0.7× 607 0.7× 294 0.4× 250 0.3× 280 1.0× 13 1.5k
M. Safford United States 10 688 0.8× 473 0.6× 267 0.3× 163 0.2× 765 2.7× 12 1.5k
Katia Beider Israel 26 473 0.5× 667 0.8× 1.2k 1.5× 91 0.1× 1.1k 3.8× 62 2.2k
David G. Coffey United States 14 610 0.7× 724 0.9× 633 0.8× 96 0.1× 324 1.1× 57 1.4k
Anastasios Karadimitris United Kingdom 31 891 1.0× 967 1.2× 640 0.8× 191 0.2× 1.3k 4.6× 91 2.7k
Annegret Van der Aa Belgium 17 402 0.5× 213 0.3× 482 0.6× 407 0.5× 495 1.7× 41 1.6k
Sonia Minuzzo Italy 21 210 0.2× 824 1.0× 397 0.5× 132 0.2× 315 1.1× 49 1.5k

Countries citing papers authored by Christopher B. Doering

Since Specialization
Citations

This map shows the geographic impact of Christopher B. Doering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher B. Doering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher B. Doering more than expected).

Fields of papers citing papers by Christopher B. Doering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher B. Doering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher B. Doering. The network helps show where Christopher B. Doering may publish in the future.

Co-authorship network of co-authors of Christopher B. Doering

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher B. Doering. A scholar is included among the top collaborators of Christopher B. Doering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher B. Doering. Christopher B. Doering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babatunde, Oluwole Adeyemi, Betsy Vaughan, John D. Owen, et al.. (2025). Transduction efficiency and vector biodistribution following prenatal vs neonatal AAV5 gene therapy for Hemophilia A in a sheep model. Blood. 146(Supplement 1). 4316–4316.
2.
George, Sunil, Denise J. Schwahn, David R. Quilici, et al.. (2023). Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity. Nature Communications. 14(1). 4206–4206. 2 indexed citations
3.
Brown, Harrison C., et al.. (2023). Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction. Journal of Thrombosis and Haemostasis. 22(3). 633–644. 2 indexed citations
4.
Lollar, Pete, et al.. (2022). SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa. Blood Advances. 6(11). 3240–3254. 5 indexed citations
5.
Kumar, Sandeep, Jun Xie, Harrison C. Brown, et al.. (2021). Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette. Molecular Therapy — Methods & Clinical Development. 23. 98–107. 12 indexed citations
6.
Doering, Christopher B., et al.. (2021). In Vivo HSC Gene Therapy with High-Level, Erythroid-Specific Expression of a Secreted SARS-CoV-2 Decoy Receptor. Molecular Therapy. 29(4). 91–92. 1 indexed citations
7.
Denning, Gabriela, Ángel A. Rivera, Miguel A. Escobar, et al.. (2021). F5‐Atlanta: A novel mutation in F5 associated with enhanced East Texas splicing and FV‐short production. Journal of Thrombosis and Haemostasis. 19(7). 1653–1665. 14 indexed citations
8.
Brown, Harrison C., Christopher B. Doering, Roland W. Herzog, et al.. (2020). Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B. Human Gene Therapy. 31(19-20). 1114–1123. 23 indexed citations
9.
Patel, Seema R., et al.. (2020). The Immune Response to the fVIII Gene Therapy in Preclinical Models. Frontiers in Immunology. 11. 494–494. 17 indexed citations
10.
George, Sunil, Anthony Atala, Christopher B. Doering, et al.. (2020). Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A. Molecular Therapy — Methods & Clinical Development. 17. 465–477. 11 indexed citations
11.
Doering, Christopher B., Gabriela Denning, Eli J. Fine, et al.. (2018). Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A. Human Gene Therapy. 29(10). 1183–1201. 45 indexed citations
12.
Denning, Gabriela, Ángel A. Rivera, Miguel A. Escobar, et al.. (2017). Factor V Atlanta: A Novel Mutation in the F5 Gene Reveals Potential New Cis-Acting Elements Involved in Regulating FV-Short and TFPI Levels. Blood. 130. 366–366. 5 indexed citations
13.
George, Sunil, Jorge Figueroa, Anthony Atala, et al.. (2017). Prenatal Transplantation of Placental Cells Engineered to Express FVIII Leads to Corrective Plasma Levels of FVIII after Birth. Blood. 130. 361–361. 2 indexed citations
14.
Raikar, Sunil S., et al.. (2017). Engineering CD5-Targeted Chimeric Antigen Receptors and Edited T Cells for the Treatment of T-Cell Leukemia. Blood. 130. 1914–1914. 9 indexed citations
15.
Tran, Reginald, David R. Myers, Gabriela Denning, et al.. (2017). Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency. Molecular Therapy. 25(10). 2372–2382. 21 indexed citations
16.
Sutton, Kathryn S., et al.. (2016). Bioengineering and serum free expansion of blood-derived γδ T cells. Cytotherapy. 18(7). 881–892. 22 indexed citations
17.
Doering, Christopher B., et al.. (2011). PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis. Value in Health. 14(7). A488–A488.
18.
Doering, Christopher B., David R. Archer, & H. Trent Spencer. (2010). Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells. Advanced Drug Delivery Reviews. 62(12). 1204–1212. 10 indexed citations
19.
Denning, Gabriela, et al.. (2009). Comparison of Factor VIII Transgenes Bioengineered for Improved Expression in Gene Therapy of Hemophilia A. Human Gene Therapy. 20(5). 465–478. 35 indexed citations
20.
Doering, Christopher B. & H. Trent Spencer. (2009). Advancements in gene transfer-based therapy for hemophilia A. Expert Review of Hematology. 2(6). 673–683. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Clise-Dwyer Breakdown of academic impact, for papers by P. Joy Ho Breakdown of academic impact, for papers by Joachim Schwäble Breakdown of academic impact, for papers by John Marken Breakdown of academic impact, for papers by M. Safford Breakdown of academic impact, for papers by Katia Beider Breakdown of academic impact, for papers by David G. Coffey Breakdown of academic impact, for papers by Anastasios Karadimitris Breakdown of academic impact, for papers by Annegret Van der Aa Breakdown of academic impact, for papers by Sonia Minuzzo
Rankless by CCL
2026